Stay updated on Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.

Latest updates to the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page
- CheckyesterdayChange DetectedThe study record has been updated from an “Active, not recruiting” state to marked as **Completed**, with corresponding changes to key **actual** dates (including the study completion date) and refreshed record metadata such as last update/verification. The site version string also changed as part of the record update.SummaryDifference0.4%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Mesangiocapillary glomerulonephritis, type II to the list of conditions.SummaryDifference0.0%

- Check30 days agoChange DetectedAdded Complement 3 glomerulopathy as a condition and removed Non-immunoglobulin-mediated membranoproliferative glomerulonephritis.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision note updated to v3.5.0; the v3.4.3 reference was removed.SummaryDifference0.0%

- Check44 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.